Yisi Tang

peking union medical college

H指数:14

被引数:1,730

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Living bacterial hydrogels for treatment of psoriasis by regulating the skin microbiome

活菌水凝胶通过调控皮肤微生物组治疗银屑病

Chinese Chemical Letters

IF8.9

2026-01-090

PRE

Interstitial drug delivery system: The physiological basis and current progress

间质药物递送系统：生理基础与当前进展

Journal of Controlled Release

IF11.5

2025-09-260

PRE

Boosting efficiency of p-i-n perovskite solar cells via enhanced interfacial dipole strength using Al2O3 nanoparticles

通过增强Al2O3纳米颗粒的界面偶极强度提升p-i-n钙钛矿太阳能电池的效率

RENEWABLE ENERGY

IF9.1

2025-05-150

PRE

Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery

ADVANCED DRUG DELIVERY REVIEWS

IF17.6

2024-06-019

PRE

Role of Micelle Size in Cell Transcytosis-Based Tumor Extravasation, Infiltration, and Treatment Efficacy

NANO LETTERS

IF9.1

2023-04-1215

PRE

A novel homozygous mutation in LSS gene possibly causes hypotrichosis simplex in two siblings of a Tibetan family from the western Sichuan province of China

FRONTIERS IN PHYSIOLOGY

IF3.4

2023-01-061

OAAI

Mucus Penetrating and Cell-Binding Polyzwitterionic Micelles as Potent Oral Nanomedicine for Cancer Drug Delivery

粘液穿透和细胞结合的聚两性离子胶束作为有效的口服纳米药物用于癌症药物递送

ADVANCED MATERIALS

IF26.8

2022-03-1385

PRE

Genetically-engineered all-in-one vaccine platform for cancer immunotherapy

ACTA PHARMACEUTICA SINICA B

IF14.6

2021-11-019

OAAI

Recombinant cancer nanovaccine for targeting tumor-associated macrophage and remodeling tumor microenvironment

靶向肿瘤相关巨噬细胞和重塑肿瘤微环境的重组癌症纳米疫苗

NANO TODAY

IF10.9

2021-10-0121

PREAI

Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity

JOURNAL OF CONTROLLED RELEASE

IF11.5

2021-01-0131

PREAI

Dual-Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug-Resistant Cancer Therapy (vol 27, 1700403, 2017)

ADVANCED FUNCTIONAL MATERIALS

IF19

2020-04-201

OAAI

Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis (vol 9, pg 26648, 2017)

通过纳米自组装共递送天花粉蛋白和阿苯达唑，以克服肿瘤的多药耐药性和转移 (第9卷，26648页，2017)

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2019-12-312

OAAI

Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1

通过仿生靶向共递送紫草素/JQ1重编程肿瘤免疫微环境 (时间) 和代谢

NANO LETTERS

IF9.1

2019-04-05145

PREAI

Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophagemediated immunotherapy

CHEMICAL SCIENCE

IF7.4

2018-01-01210

OAAI

Co-Delivery of Trichosanthin and Albendazole by Nano-Self Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis

通过纳米自组装共递送天花粉蛋白和阿苯达唑，以克服肿瘤的多药耐药和转移

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2017-08-0384

PREAI

Dual-Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug-Resistant Cancer Therapy

通过仿生递送甘露糖化白蛋白纳米颗粒双重靶向癌细胞和M2巨噬细胞，用于耐药癌症治疗

ADVANCED FUNCTIONAL MATERIALS

IF19

2017-07-10150

PREAI

Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature

BIOMATERIALS

IF12.9

2017-02-0151

OAAI

Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy

ACS NANO

IF16

2016-11-08397

PREAI

Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer

核靶向TAT-PEG-Asp8-doxorubicin聚合物纳米组装克服耐药性结肠癌

ACTA PHARMACOLOGICA SINICA

IF8.4

2016-06-1323

OAAI

Yisi Tang

个人简介

教育背景

工作经历

荣誉奖项

研究方向